Related Experiment Video
Updated: Jul 18, 2026

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Effect of interaction between left ventricular dysfunction and endothelial function in hypertension
Angela Sciacqua1, Francesco Borrello, Marco Vatrano
1Department of Medicina Sperimentale e Clinica, Policlinico Mater Domini, Via Tommaso Campanella, 88100 Catanzaro, Italy.
Insights
Hypertension is linked to left ventricular hypertrophy and endothelial dysfunction, increasing cardiovascular risks. Addressing both conditions is crucial for better outcomes in hypertensive patients.
Area of Science:
- Cardiology
- Vascular Biology
Background:
- Hypertension is a major risk factor for cardiovascular diseases.
- Left ventricular hypertrophy and endothelial dysfunction are independent predictors of clinical events.
- Endothelial dysfunction impairs antiatherosclerotic and antithrombotic functions, promoting atherosclerosis.
- Left ventricular hypertrophy independently predicts cardiovascular morbidity and mortality, predisposing to arrhythmias and worsening ischemia outcomes.
Purpose of the Study:
- To highlight the clinical significance of left ventricular hypertrophy and endothelial dysfunction in hypertension.
- To emphasize the interaction between endothelial dysfunction and left ventricular mass.
- To advocate for aggressive therapeutic strategies targeting both conditions in hypertensive patients.
Main Methods:
- This study is a review of existing literature and clinical observations.
- Analysis focuses on the independent and combined roles of left ventricular hypertrophy and endothelial dysfunction in hypertensive patients.
- Clinical implications of the interaction between these two conditions are discussed.
Main Results:
- Left ventricular hypertrophy and endothelial dysfunction are significant risk factors in hypertension.
- A dysfunctioning endothelium promotes atherosclerosis.
- Left ventricular hypertrophy increases the risk of arrhythmias and myocardial ischemia complications.
- The coexistence of left ventricular hypertrophy and endothelial dysfunction nearly doubles the risk of vascular events in hypertensive individuals.
Conclusions:
- There is a significant interaction between endothelial dysfunction and left ventricular mass in hypertensive patients.
- The combined presence of left ventricular hypertrophy and endothelial dysfunction substantially elevates the risk of future vascular events.
- Aggressive therapeutic strategies aimed at reducing left ventricular mass and improving endothelial function are clinically beneficial for hypertensive patients.
Abstract:
Hypertension, one of the most important risk factors for cardiovascular diseases, is associated with both left ventricular hypertrophy and endothelial dysfunction. Both have been recently recognized as independent predictors of clinical events in different groups of patients. In fact, a dysfunctioning endothelium loses its antiatherosclerotic and antithrombotic action, and, therefore, promotes the atherosclerotic process. Similarly, cardiac hypertrophy is recognized as a powerful and independent risk factor for cardiovascular morbidity and mortality because it predisposes to arrhythmias and maximizes the consequences of acute myocardial ischemia. Recently, an evident interaction has been demonstrated between endothelial dysfunction and left ventricular mass. In particular, the coexistence of both left ventricular hypertrophy and endothelial dysfunction almost doubles the risk for future vascular events in hypertensives. Thus, in hypertensive patients, it is clinically useful to choose an aggressive therapeutic strategy--to reduce left ventricular mass and to improve endothelial function.
More Related Videos
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
08:57Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Mitral Regurgitation I: Introduction
Hypertension II: Pathophysiology
Heart Failure I: Introduction